Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Clinical Validation of Birch Pollen in the EEU

Not Applicable

Completed

Conditions: Allergic Rhinitis

First Posted Date: 2015-01-30

Last Posted Date: 2015-04-21

Lead Sponsor: Queen's University

Target Recruit Count: 59

Registration Number: NCT02351830

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD

Completed

Conditions: COPD

First Posted Date: 2015-01-27

Last Posted Date: 2015-11-20

Lead Sponsor: Queen's University

Target Recruit Count: 22

Registration Number: NCT02346604

Locations: 🇨🇦
Respiratory Investigation Unit at Kingston General Hospital, Kingston, Ontario, Canada

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

Phase 1

Completed

Conditions: Recurrent Lymphoma
Refractory Lymphoma
Solid Tumours
Central Nervous System

Interventions: Drug: Vinblastine
Drug: Temsirolimus

First Posted Date: 2015-01-22

Last Posted Date: 2023-08-04

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 7

Registration Number: NCT02343718

Locations: 🇨🇦
Children's and Women's Health Centre of BC Branch, Vancouver, British Columbia, Canada
🇨🇦
Izaak Walton Killam (IWK) Health Centre, Halifax, Nova Scotia, Canada
🇨🇦
McMaster Children's Hospital, Hamilton, Ontario, Canada

and more 3 locations

Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness

Completed

Conditions: Sepsis
Respiratory Failure
Critical Illness
Delirium

Interventions: Device: Near infrared spectroscopy

First Posted Date: 2015-01-22

Last Posted Date: 2016-11-28

Lead Sponsor: Queen's University

Target Recruit Count: 116

Registration Number: NCT02344043

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Chronic Lymphocytic Leukemia

Interventions: Drug: Buparlisib

First Posted Date: 2015-01-19

Last Posted Date: 2023-08-22

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 14

Registration Number: NCT02340780

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada

and more 3 locations

Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC

Phase 2

Completed

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: Selumetinib
Drug: Pemetrexed
Drug: Cisplatin
Drug: Carboplatin

First Posted Date: 2015-01-13

Last Posted Date: 2024-03-21

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 62

Registration Number: NCT02337530

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
BCCA - Abbotsford Centre, Abbotsford, British Columbia, Canada

and more 9 locations

MindLight: A Video Game Intervention to Reduce Children's Anxiety

Phase 2

Conditions: Anxiety

Interventions: Behavioral: Online CBT
Behavioral: MindLight

First Posted Date: 2014-12-29

Last Posted Date: 2016-04-01

Lead Sponsor: Queen's University

Target Recruit Count: 200

Registration Number: NCT02326545

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis

Phase 4

Completed

Conditions: Osteoarthritis, Knee

Interventions: Other: Myofascial-specific therapy
Behavioral: Standard Physiotherapy

First Posted Date: 2014-12-19

Last Posted Date: 2018-04-06

Lead Sponsor: Queen's University

Target Recruit Count: 50

Registration Number: NCT02320500

Locations: 🇨🇦
Hotel Dieu Hospital, Kingston, Ontario, Canada

MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours

Phase 1

Active, not recruiting

Conditions: Advanced/Metastatic Solid Tumours

Interventions: Biological: MG1MA3
Biological: AdMA3

First Posted Date: 2014-11-07

Last Posted Date: 2025-03-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 56

Registration Number: NCT02285816

Locations: 🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

and more 1 locations

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Phase 3

Active, not recruiting

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: MEDI4736
Drug: Placebo

First Posted Date: 2014-10-24

Last Posted Date: 2024-10-31

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 1415

Registration Number: NCT02273375

Locations: 🇺🇸
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
🇺🇸
USC Norris/Comprehensive Cancer Centre, Los Angeles, California, United States
🇺🇸
National Jewish Health, Denver, Colorado, United States

and more 267 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy